Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results